Global
   
Include All CSL Behring Country Sites

Australia

Plasma-Derived Therapies

Product Name Subcategory Description Business
BIOSTATE® Coagulation Disorders Used for patients with haemophilia A, in which there are reduced levels of factor VIII. CSL Biotherapies
BERINERT® Critical Care Used for the treatment of acute attacks in patients with hereditary angioedema. CSL Biotherapies
MonoFIX®-VF Coagulation Disorders Used in patients with haemophilia B, in which there are reduced levels of Factor IX. CSL Biotherapies
PROTHROMBINEX®-VF Coagulation Disorders Used for the prevention and treatment of bleeding in patients with reduced levels of factor IX, II or X. CSL Biotherapies
ALBUMEX®  4 Critical Care Used when the blood volume is low, during heart-lung bypass surgery, and in plasma exchange. CSL Biotherapies
ALBUMEX® 20 Critical Care Used when quantity of albumin in blood is low, for resuscitation in shock, in extensive burns, respiratory distress syndrome, blood purification and plasma exchange. CSL Biotherapies
THROMBOTROL®-VF Critical Care Used for the treatment of patients with conditions relating to an inherited deficiency of antithrombin III. CSL Biotherapies
CMV Immunoglobulin-VF Immune Therapy Used to help prevent cytomegalovirus infection in specific transplant patients. CSL Biotherapies
Hepatitis B Immunoglobulin-VF Immune Therapy Used to help prevent hepatitis B infection in a person who comes into contact with suspected infected material. CSL Biotherapies
INTRAGAM® P Immune Therapy Used to replace antibodies to help prevent infections and also used in the treatment of some autoimmune disorders. CSL Biotherapies
Normal Immunoglobulin-VF Immune Therapy Used for the replacement of antibodies to help prevent infections. CSL Biotherapies
Rh(D) Immunoglobulin-VF Immune Therapy Used to prevent Haemolytic Disease of the Newborn. CSL Biotherapies
RHOPHYLAC® Immune Therapy Used in large fetomaternal haemorrhage (FMH), or for inadvertent or emergency transfusion of Rh (D) positive blood to an Rh (D) negative female of childbearing potential. CSL Biotherapies
RiaSTAP® Critical Care Used for treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency. CSL Biotherapies
Tetanus Immunoglobulin-VF IM Immune Therapy Used to help prevent tetanus in a person who has not recently been immunised against tetanus. CSL Biotherapies
Tetanus Immunoglobulin-VF IV Immune Therapy Used to treat tetanus infection. CSL Biotherapies
Zoster Immunoglobulin-VF Immune Therapy Used to help prevent chickenpox and shingles. CSL Biotherapies

Australia

Vaccines

Product Name Subcategory Description Business
ADT Booster®   For the prevention of diphtheria and tetanus. CSL Biotherapies
COMVAX®   For the prevention of Haemophilus influenza type b and hepatitis B infection. CSL Biotherapies
DUKORAL®   For the prevention of Cholera caused by serogroup O1 Vibrio cholera in adults and children ≥ 2 years. CSL Biotherapies
Fluvax®   For the prevention of influenza. CSL Biotherapies
GARDASIL®   For the prevention of cervical, vulvar, vaginal and anal cancer, and genital warts caused by Human Papillomavirus (HPV) Types 6,11,16 & 18. CSL Biotherapies
H-B-VAX II®   For the prevention of hepatitis B infection. CSL Biotherapies
Menjugate®   For the prevention of meningococcal group C infection. CSL Biotherapies
JESPECT   For the prevention of Japanese Encephalitis infection CSL Biotherapies
MENVEO®   For the prevention of invasive disease caused by Neisseria meningitidis serogroups A, C, W-135 and Y. CSL Biotherapies
MERUVAX II®   For the prevention of rubella. CSL Biotherapies
PedvaxHIB®   For the prevention of Haemophilus influenza type b. CSL Biotherapies
PNEUMOVAX 23®   For the prevention of pneumococcal infections. CSL Biotherapies
Q-VAX®   For the prevention of Q fever. CSL Biotherapies
Rabipur®   For the prevention of rabies. CSL Biotherapies
RotaTeq®   For the prevention of gastroenteritis. CSL Biotherapies
VAQTA®   For the prevention of hepatitis A infection. CSL Biotherapies
VARIVAX Refrigerated®   For the prevention of chickenpox. CSL Biotherapies
Vivotif Oral®   For the prevention of typhoid. CSL Biotherapies
ZOSTAVAX®   For the prevention of shingles. CSL Biotherapies

Australia

Pharmaceuticals

Product Name Subcategory Description Business
Advantan Dermatology Indicated for the treatment of eczema and psoriasis. CSL Biotherapies
Angiomax Cardiovascular Used to help prevent unwanted blood clotting during an "angioplasty." CSL Biotherapies
BenPen Antibiotics Used to treat infections caused by susceptible bacteria. CSL Biotherapies
Burinex Urology Indicated for the treatment of oedema, particularly when associated with congestive heart failure, hepatic and renal diseases. CSL Biotherapies
Cervidil Obstetrics and Gynecology Used by women who have a normal pregnancy and are near their due date for delivery to prepare for induction. CSL Biotherapies
Finacea Dermatology Topical treatment for papulo-pustular rosacea and mild-to-moderate acne vulgaris. CSL Biotherapies
Flomaxtra Urology Treatment for men which relieves the lower urinary tract symptoms (LUTS) associated with a condition called benign prostatic hyperplasia (BPH). CSL Biotherapies
Fucidin Antibiotics Used to treat serious infections caused by susceptible bacteria that have not responded to other antibiotics. CSL Biotherapies
Minijet Adrenaline Emergency Care Used in the management of Cardiac Arrest. CSL Biotherapies
Minijet Atropine Sulfate Emergency Care Used in the management of heart rate abnormalities following Cardiac Arrest. CSL Biotherapies
Minijet Calcium Chloride Emergency Care Used in the management of Cardiac Arrest and treating specific biochemical abnormalities in the blood. CSL Biotherapies
Minijet Glucose Emergency Care Used in the management of low blood sugar level that has led to loss of consciousness. CSL Biotherapies
Minijet Lignocaine Hydrochloride Emergency Care Used to correct severe abnormalities of cardiac rhythm. CSL Biotherapies
Minijet Naloxone Hydrochloride Emergency Care Used in the management of overdose of any opioid medication. CSL Biotherapies
Minijet Sodium Bicarbonate Emergency Care Used to help correct the biochemical abnormality of excess acid in the blood which results from Cardiac Arrest. CSL Biotherapies
Modavigil Central Nervous System A wakefulness-promoting agent for oral administration. CSL Biotherapies
Nebilet Cardiovascular Treatment for stable chronic heart failure and may also be used to treat essential hypertension. CSL Biotherapies
Scheriproct Ointment Urology Used in the treatment of haemorrhoids(piles), tears of the anal tissue, and similar conditions. CSL Biotherapies
Solaraze Dermatology Used to manage the skin condition known as actinic or solar keratosis. CSL Biotherapies
Tramal Analgesia Used to treat moderate to severe pain. CSL Biotherapies
Vaniqa Dermatology Used to delay the regrowth of unwanted facial hair in women. CSL Biotherapies
Vesicare Urology For the treatment of overactive bladder. CSL Biotherapies

Australia

Antivenoms

Product Name Subcategory Description Business
Black Snake Antivenom   For the treatment of symptoms of a venomous bite. CSL Biotherapies
Box Jellyfish Antivenom   For the treatment of symptoms of a venomous sting. CSL Biotherapies
Brown Snake Antivenom   For the treatment of symptoms of a venomous bite. CSL Biotherapies
Death Adder Antivenom   For the treatment of symptoms of a venomous bite. CSL Biotherapies
Funnel Web Spider Antivenom   For the treatment of symptoms of a venomous bite. CSL Biotherapies
Polyvalent Snake Antivenom   For the treatment of symptoms of a venomous bite. CSL Biotherapies
Red Back Spider Antivenom   For the treatment of symptoms of a venomous bite. CSL Biotherapies
Sea Snake Antivenom   For the treatment of symptoms of a venomous bite. CSL Biotherapies
Stonefish Antivenom   For the treatment of symptoms of a venomous sting. CSL Biotherapies
Taipan Antivenom   For the treatment of symptoms of a venomous bite. CSL Biotherapies
Tiger Snake Antivenom   For the treatment of symptoms of a venomous bite. CSL Biotherapies

Australia

Immunohaematology (Diagnostic Reagents)

Product Name Subcategory Description Business
A2 Cells 3% Reagent Red Blood Cells Used to detect ABO blood group antibodies and identifying A1 and A2 subgroups. CSL Biotherapies
Abtectcell™ II 0.8% Reagent Red Blood Cells Used to detect unexpected alloantibodies using Column Agglutination Technology (CAT) Systems. CSL Biotherapies
Abtectcell™ II 0.8% Pooled Reagent Red Blood Cells Used in detecting unexpected alloantibodies. CSL Biotherapies
Abtectcell™ II 3% Reagent Red Blood Cells Used to detect unexpected alloantibodies using tube technique. CSL Biotherapies
Abtectcell™ III 0.8% Reagent Red Blood Cells Used to detect unexpected alloantibodies using Column Agglutination Technology (CAT) Systems. CSL Biotherapies
Abtectcell™ III 0.8% RhD Negative Screening Cells Reagent Red Blood Cells Used in detecting unexpected alloantibodies other than anti-D. CSL Biotherapies
Abtectcell™ III 3% Reagent Red Blood Cells Used to detect unexpected alloantibodies using tube technique. CSL Biotherapies
AHG Anti-IgG Anti-Human Globulin Reagent Used for detection of clinically relevant IgG subtypes. CSL Biotherapies
AHG Control Cells 3% Reagent Red Blood Cells Used for the confirmation of antiglobulin activity. CSL Biotherapies
Anti-A1 ABO Reagent Used to detect Group A1 red cells. CSL Biotherapies
Anti-Fya Phenotyping Reagent Used to detect the presence of the Fya antigen on human red cells. CSL Biotherapies
Anti-Fyb Phenotyping Reagent Used to detect the presence of the Fyb antigen on human red cells. CSL Biotherapies
Anti-k (Cellano) Phenotyping Reagent Used to detect the presence of the k (Cellano) antigen on human red cells. CSL Biotherapies
Anti-Kpa Phenotyping Reagent Used to detect the presence of the Kpa antigen on human red cells. CSL Biotherapies
Bovine Albumin 22% Solution Supplementary Reagent Used to enhance the agglutination of red cells in antibody detection tests. CSL Biotherapies
Bovine Albumin 30% Solution Supplementary Reagent Used to enhance the agglutination of red cells in antibody detection tests. CSL Biotherapies
Celpresol™ Supplementary Reagent Designed for the preservation, suspension and resuscitation of human red blood cells. CSL Biotherapies
Celpresol™ LISS Supplementary Reagent Designed for the preservation, suspension and resuscitation of human red blood cells. CSL Biotherapies
Controcell™ 2
(EU and US only) 		Reagent Red Blood Cells Designed to control, standardise and validate all routine immunohaematology tests. CSL Biotherapies
Controcell™ 4
(EU and US only) 		Reagent Red Blood Cells Designed to control, standardise and validate all routine immunohaematology tests. CSL Biotherapies
Cord Cells 3% Reagent Red Blood Cells Used for confirming the presence of anti-I in an antibody identification procedure. CSL Biotherapies
Epiclone™ AHG Poly Anti-Human Globulin Reagent Used for detection of clinically relevant IgG subtypes. CSL Biotherapies
Epiclone™ Anti-A ABO Reagent Used to detect the presence of the A antigen on human red cells. CSL Biotherapies
Epiclone™ Anti-A/B ABO Reagent Used to detect the presence of the A and B antigens on human red cells. CSL Biotherapies
Epiclone™ Anti-B ABO Reagent Used to detect the presence of the B antigen on human red cells. CSL Biotherapies
Epiclone™ Anti-C Phenotyping Reagent Used to detect the presence of the C antigen on human red cells. CSL Biotherapies
Epiclone™ Anti-c Phenotyping Reagent Used to detect the presence of the c antigen on human red cells. CSL Biotherapies
Epiclone™ Anti-C3d Anti-Human Globulin Reagent Used to only detect the clinically relevant complement components in relation to Anti-C3d. CSL Biotherapies
Epiclone™ Anti-Cw Phenotyping Reagent Used to detect the presence of the Cw antigen on human red cells. CSL Biotherapies
Epiclone™ Anti-DCE Phenotyping Reagent Used to detect the presence of the D, C and E antigens on human red cells. CSL Biotherapies
Epiclone™ Anti-E Phenotyping Reagent Used to detect the presence of the E antigen on human red cells. CSL Biotherapies
Epiclone™ Anti-e Phenotyping Reagent Used to detect the presence of the e antigen on human red cells. CSL Biotherapies
Epiclone™ Anti-Jka Phenotyping Reagent Used to detect the presence of the Jka antigen on human red cells. CSL Biotherapies
Epiclone™ Anti-Jkb Phenotyping Reagent Used to detect the presence of the Jkb antigen on human red cells. CSL Biotherapies
Epiclone™ Anti-K (Kell) Phenotyping Reagent Used to detect the presence of the K antigen on human red cells. CSL Biotherapies
Epiclone™ Anti-Lea Phenotyping Reagent Used to detect the presence of the Lea antigen on human red cells. CSL Biotherapies
Epiclone™ Anti-Leb Phenotyping Reagent Used to detect the presence of the Leb antigen on human red cells. CSL Biotherapies
Epiclone™ Anti-M Phenotyping Reagent Used to detect the presence of the M antigen on human red cells. CSL Biotherapies
Epiclone™ Anti-N Phenotyping Reagent Used to detect the presence of the N antigen on human red cells. CSL Biotherapies
Epiclone™ Anti-P1 Phenotyping Reagent Used to detect the presence of the P1 antigen on red blood cells. CSL Biotherapies
Epiclone™ Anti-s Phenotyping Reagent Used to detect the presence of the s antigen on human red cells. CSL Biotherapies
Epiclone™ Anti-S Phenotyping Reagent Used to detect the presence of the S antigen on human red cells. CSL Biotherapies
Epiclone™-2 Anti-D (IgM) RhD Reagent Used to detect the presence of RhD positive human red cells. CSL Biotherapies
Epiclone™-2 Anti-D (IgM/IgG) RhD Reagent Designed for routine RhD typing of human red cells. CSL Biotherapies
LISS Supplementary Reagent Designed for use in tube technique antibody screening, identification and cross matching. CSL Biotherapies
Papain Solution Supplementary Reagent Used to treat human red cells in immunohaematological testing. CSL Biotherapies
Phenocell™ 0.8% Reagent Red Blood Cells Used in identification of unexpected alloantibodies using Column Agglutination Technology (CAT) Systems. CSL Biotherapies
Phenocell™ 3% Reagent Red Blood Cells Used in identification of unexpected alloantibodies using tube technique. CSL Biotherapies
Phenocell 0.8% (C Panel) Reagent Red Blood Cells Used in identification of unexpected rare and unusual alloantibodies using Column Agglutination Technology (CAT) Systems. CSL Biotherapies
Phenocell 3% (C Panel) Reagent Red Blood Cells Used in identification of unexpected rare and unusual alloantibodies using tube technique. CSL Biotherapies
RAM Supplementary Reagent Designed for use in tube technique antibody screening, identification and cross matching. CSL Biotherapies
RAMPEG Supplementary Reagent Designed for use in tube technique antibody screening and identification. CSL Biotherapies
Revercell™ 0.8% Reagent Red Blood Cells Used to detect ABO blood group antibodies using Column Agglutination Technology (CAT) Systems. CSL Biotherapies
Revercell™ 15% Reagent Red Blood Cells Used to detect ABO blood group antibodies using tile techniques. CSL Biotherapies
Revercell™ 3% Reagent Red Blood Cells Used to detect ABO blood group antibodies using tube techniques. CSL Biotherapies
Securacell™ Reagent Red Blood Cells Designed to control, standardise and validate all routine immunohaematology tests. CSL Biotherapies
Securacell™ Light Reagent Red Blood Cells Designed to control, standardise and validate all routine immunohaematology tests. CSL Biotherapies
Snake Venom Detection Kit (SVDK) Snake Venom Detection Designed to assist in selection of most appropriate monovalent antivenom therapy. CSL Biotherapies
Venom Practice Kit (VPK) Snake Venom Detection Used in identifying snake immunotype for selecting appropriate antivenoms. CSL Biotherapies

Austria

Austria Products

To Find More About Austria Products click on Austria General Product Info

Brazil

Brazil Products

To Find More About Brazil Products click on Brazil General Product Info

China

China Products

To Find More About China Products click on China General Product Info

Germany

Germany Products

To Find More About Germany Products click on Germany General Product Info

Hong Kong

Plasma-Derived Therapies

Product Name Subcategory Description Business
BIOSTATE® Coagulation Disorders Used for patients with haemophilia A, in which there are reduced levels of factor VIII. CSL Biotherapies
PROTHROMBINEX™-HT Coagulation Disorders Used for the prevention and treatment of bleeding in patients with reduced levels of factor IX, II or X. CSL Biotherapies
 Albumex® 5 Critical Care Used when the blood volume is low, during heart-lung bypass surgery, and in plasma exchange. CSL Biotherapies
Albumex® 20 Critical Care Used when quantity of albumin in blood is low, for resuscitation in shock, in extensive burns, respiratory distress syndrome, blood purification and plasma exchange. CSL Biotherapies
INTRAGAM® P Immune Therapy Used to replace antibodies to help prevent infections and also used in the treatment of some autoimmune disorders. CSL Biotherapies

India

Immunohaematology (Diagnostic Reagents)

Product Name Subcategory Description Business
Epiclone™ Anti-A FFMU Concentrate ABO Reagent Concentrated formulation of ABO blood grouping materials for further manufacturing use. CSL Biotherapies
Epiclone™ Anti-B FFMU Concentrate ABO Reagent Concentrated formulation of ABO blood grouping materials for further manufacturing use. CSL Biotherapies
Epiclone™ Anti-A/B FFMU Concentrate ABO Reagent Concentrated formulation of ABO blood grouping materials for further manufacturing use. CSL Biotherapies
Epiclone™ Anti-C3d FFMU Concentrate Anti-Human Globulin Reagent Concentrated formulation of Anti-C3d blood grouping materials for further manufacturing use. CSL Biotherapies
Epiclone™-2 Anti-D (IgM) FFMU Concentrate RhD Reagent Concentrated formulation of RhD blood grouping materials for further manufacturing use. CSL Biotherapies
Epiclone™ Anti-D (IgG) FFMU Concentrate RhD Reagent Concentrated formulation of RhD blood grouping materials for further manufacturing use. CSL Biotherapies
Epiclone™-2 Anti-D (IgM/IgG) FFMU Concentrate RhD Reagent Concentrated formulation of RhD blood grouping materials for further manufacturing use. CSL Biotherapies
Epiclone™ Anti-ABO FFMU Concentrate Diluting Buffer Supplementary Reagent Diluting buffer powder containing a formulation of components to manufacture an appropriate Diluent Reagent for making up FFMU Concentrates into finished reagents. CSL Biotherapies
Epiclone™ Anti-D FFMU Concentrate Diluting Buffer Supplementary Reagent Diluting buffer powder containing a formulation of components to manufacture an appropriate Diluent Reagent for making up FFMU Concentrates into finished reagents. CSL Biotherapies

Indonesia

Immunohaematology (Diagnostic Reagents)

Product Name Subcategory Description Business
Epiclone™ Anti-A FFMU Concentrate ABO Reagent Concentrated formulation of ABO blood grouping materials for further manufacturing use. CSL Biotherapies
Epiclone™ Anti-B FFMU Concentrate ABO Reagent Concentrated formulation of ABO blood grouping materials for further manufacturing use. CSL Biotherapies
Epiclone™ Anti-A/B FFMU Concentrate ABO Reagent Concentrated formulation of ABO blood grouping materials for further manufacturing use. CSL Biotherapies
Epiclone™ Anti-C3d FFMU Concentrate Anti-Human Globulin Reagent Concentrated formulation of Anti-C3d blood grouping materials for further manufacturing use. CSL Biotherapies
Epiclone™-2 Anti-D (IgM) FFMU Concentrate RhD Reagent Concentrated formulation of RhD blood grouping materials for further manufacturing use. CSL Biotherapies
Epiclone™ Anti-D (IgG) FFMU Concentrate RhD Reagent Concentrated formulation of RhD blood grouping materials for further manufacturing use. CSL Biotherapies
Epiclone™-2 Anti-D (IgM/IgG) FFMU Concentrate RhD Reagent Concentrated formulation of RhD blood grouping materials for further manufacturing use. CSL Biotherapies
Epiclone™ Anti-ABO FFMU Concentrate Diluting Buffer Supplementary Reagent Diluting buffer powder containing a formulation of components to manufacture an appropriate Diluent Reagent for making up FFMU Concentrates into finished reagents. CSL Biotherapies
Epiclone™ Anti-D FFMU Concentrate Diluting Buffer Supplementary Reagent Diluting buffer powder containing a formulation of components to manufacture an appropriate Diluent Reagent for making up FFMU Concentrates into finished reagents. CSL Biotherapies

Italy

Italy Products

To Find More About Italy Products click on Italy General Product Info

Japan

Japan Products

To Find More About Japan Products click on Japan General Product Info

Malaysia

Plasma-Derived Therapies

Product Name Subcategory Description Business
BIOSTATE™ Coagulation Disorders Used for patients with haemophilia A, in which there are reduced levels of factor VIII. CSL Biotherapies
PROTHROMBINEX™-HT Coagulation Disorders Used for the prevention and treatment of bleeding in patients with reduced levels of factor IX, II or X. CSL Biotherapies
ALBUMEX® 20 Critical Care Used when quantity of albumin in blood is low, for resuscitation in shock, in extensive burns, respiratory distress syndrome, blood purification and plasma exchange. CSL Biotherapies
INTRAGAM® P Immune Therapy Used to replace antibodies to help prevent infections and also used in the treatment of some autoimmune disorders. CSL Biotherapies

Mexico

Mexico Products

To Find More About Mexico Products click on Mexico General Product Info

New Zealand

Vaccines & Pharmaceuticals

For information on vaccines in New Zealand, please visit CSL Biotherapies NZ

New Zealand

Plasma-Derived Therapies

Product Name Subcategory Description Business
BIOSTATE® Coagulation Disorders Used for patients with haemophilia A, in which there are reduced levels of factor VIII. CSL Biotherapies
MonoFIX®-VF Coagulation Disorders Used in patients with haemophilia B, in which there are reduced levels of Factor IX. CSL Biotherapies
ALBUMEX®  4 Critical Care Used when the blood volume is low, during heart-lung bypass surgery, and in plasma exchange. CSL Biotherapies
ALBUMEX® 20 Critical Care Used when quantity of albumin in blood is low, for resuscitation in shock, in extensive burns, respiratory distress syndrome, blood purification and plasma exchange. CSL Biotherapies
THROMBOTROL®-VF Critical Care Used for the treatment patients with conditions relating to an inherited deficiency of antithrombin III. CSL Biotherapies
Hepatitis B Immunoglobulin-VF Immune Therapy Used to help prevent hepatitis B infection in a person who comes into contact with suspected infected material. CSL Biotherapies
INTRAGAM® P Immune Therapy Used to replace antibodies to help prevent infections and also used in the treatment of some autoimmune disorders. CSL Biotherapies
Normal Immunoglobulin-VF Immune Therapy Used for the replacement of antibodies to help prevent infections. CSL Biotherapies
Rh(D) Immunoglobulin-VF Immune Therapy Used to prevent Haemolytic Disease of the Newborn. CSL Biotherapies
Tetanus Immunoglobulin-VF IM Immune Therapy Used to help prevent tetanus in a person who has not recently been immunised against tetanus. CSL Biotherapies
PROTHROMBINEX™-VF Coagulation Disorders Used for the prevention and treatment of bleeding in patients with reduced levels of factor IX, II or X. CSL Biotherapies
Zoster Immunoglobulin-VF Immune Therapy Used to help prevent chickenpox and shingles. CSL Biotherapies

Nordic

Nordic Products

To Find More About Nordic Products click on Nordic General Product Info

Singapore

Plasma-Derived Therapies

Product Name Subcategory Description Business
BIOSTATE® Coagulation Disorders Used for patients with haemophilia A, in which there are reduced levels of factor VIII. CSL Biotherapies
20% NSA Critical Care Used when quantity of albumin in blood is low, for resuscitation in shock, in extensive burns, respiratory distress syndrome, blood purification and plasma exchange. CSL Biotherapies
INTRAGAM® P Immune Therapy Used to replace antibodies to help prevent infections and also used in the treatment of some autoimmune disorders. CSL Biotherapies

Spain

Spain Products

To Find More About Spain Products click on Spain General Product Info

Switzerland

Switzerland Products

To Find More About Switzerland Products click on Switzerland General Product Info

United Kingdom

United Kingdom Products

To Find More About United Kingdom Products click on UK General Product Info

United States

United States Products

To Find More About United States Products click on USA General Product Info